Os desafios da indústria farmacêutica global e o redesenho do negócio pela Merck

Gilson Nunes de Paula

RAE - Revista de Administração de Empresas, 2001, vol. 41, issue 1

Abstract: The article tries to answer the following questions: based on the changes in the global pharmaceutical industry that are in process nowadays, which company is prepared to lead the competition into the future? What differentiates this company from other competitors? What is this leader doing in this sense? In our view, this leader company is Merck, and whatdifferentiates it from the others is the vision of the future for the business and the strategic initiatives that Merck has implemented following its vision, which have impacted on the whole pharmaceutical industry as well. It is the capability of the company to create a rupture with the current business model.

Date: 2001
References: Add references at CitEc
Citations:

Downloads: (external link)
http://bibliotecadigital.fgv.br/ojs/index.php/rae/article/view/37665 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:fgv:eaerae:v:41:y:2001:i:1:a:37665

Access Statistics for this article

RAE - Revista de Administração de Empresas is currently edited by Eduardo Diniz

More articles in RAE - Revista de Administração de Empresas from FGV-EAESP Escola de Administração de Empresas de São Paulo (Brazil)
Bibliographic data for series maintained by Núcleo de Computação da FGV EPGE ().